NASDAQ:NAOV NanoVibronix (NAOV) Stock Price, News & Analysis → Trump’s “Tax Free” Retirement Strategy (From Gold Safe Exchange) (Ad) Free NAOV Stock Alerts $0.72 +0.01 (+1.42%) (As of 12:32 PM ET) Add Compare Share Share Today's Range$0.72▼$0.7550-Day Range$0.69▼$0.9452-Week Range$0.68▼$4.34Volume10,668 shsAverage Volume81,526 shsMarket Capitalization$2.01 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Get NanoVibronix alerts: Email Address Ad Monetary GoldTrump Reveals Conspiracy Behind Fed-Controlled Digital Currency.Donald Trump once again sounded the alarm against Fed-controlled digital currencies (CBDCs). If these plans are implemented, it could mean the end of America as we know it.This means you must act NOW before it's too late. About NanoVibronix Stock (NASDAQ:NAOV)NanoVibronix, Inc., through its subsidiary, NanoVibronix Ltd., focuses on the manufacture and sale of noninvasive biological response-activating devices that target biofilm prevention, wound healing, and pain therapy. Its product portfolio includes UroShield, an ultrasound-based product to prevent bacterial colonization and biofilm in urinary catheters, enhance antibiotic efficacy, and decrease pain and discomfort associated with urinary catheter use. The company also offers PainShield, a patch-based therapeutic ultrasound technology to treat pain, muscle spasm, and joint contractures; and WoundShield, a patch-based therapeutic ultrasound device intended to facilitate tissue regeneration and wound healing by using ultrasound to increase local capillary perfusion and tissue oxygenation. It sells its products directly to patients, as well as through distributor agreements in the United States, Israel, Europe, Australia, India, and internationally. The company was incorporated in 2003 and is headquartered in Elmsford, New York.Read More NAOV Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart NAOV Stock News HeadlinesMay 16 at 8:30 AM | businesswire.comNanoVibronix Issues Letter to StockholdersMay 16 at 1:12 AM | investorplace.comNAOV Stock Earnings: NanoVibronix Reported Results for Q1 2024May 14 at 9:48 AM | finance.yahoo.comNanoVibronix Announces Distribution Agreement with VA Supplier CB Medical for the Distribution of UroShieldMay 1, 2024 | businesswire.comNanoVibronix Announces PainShield Will Be Included in Department of Veteran Affairs' FSS Contract AwardApril 10, 2024 | investorplace.comNAOV Stock Earnings: NanoVibronix Reported Results for Q4 2023April 9, 2024 | businesswire.comNanoVibronix Issues Letter to StockholdersMarch 28, 2024 | finance.yahoo.comNanoVibronix Signs Agreement for Research and Development of Next Generation PainShield and UroShieldFebruary 23, 2024 | benzinga.comMagnolia Oil & Gas Stock (NYSE:MGY), Quotes and News SummaryFebruary 2, 2024 | uk.finance.yahoo.comNanoVibronix, Inc. (NAOV)January 7, 2024 | morningstar.comNanoVibronix Inc NAOVDecember 6, 2023 | finance.yahoo.comNanoVibronix Featured in Your Bladder Health MagazineDecember 4, 2023 | finance.yahoo.comNanoVibronix Enters into Letter of Intent with APOGEPHA Arzneimittel GmbH to Explore European Distribution OpportunityNovember 28, 2023 | markets.businessinsider.comNanoVibronix Stock Slips 10%, Sings Research Agreement With Regents Of The University Of MichiganNovember 28, 2023 | finance.yahoo.comNanoVibronix Announces Agreement for Clinical Study of UroShield at the University of MichiganNovember 7, 2023 | finance.yahoo.comNanoVibronix UroShield Products Available on NHS Drug Tariff Effective November 1September 27, 2023 | finanznachrichten.deNanoVibronix, Inc.: NanoVibronix Gains Approval for Inclusion of UroShield Products in NHS Prescription Services' Drug TariffSeptember 27, 2023 | finance.yahoo.comNanoVibronix Gains Approval for Inclusion of UroShield Products in NHS Prescription Services’ Drug TariffSeptember 6, 2023 | finance.yahoo.comNanoVibronix Announces Presentation of Positive Independent Testing Results of UroShield at ICS Annual MeetingAugust 31, 2023 | seekingalpha.comAMC, MMLP and ARAV among mid-day moversAugust 30, 2023 | msn.comNanoVibronix to raise $5M through private placementAugust 30, 2023 | finance.yahoo.comWhy Is NanoVibronix Stock Trading Higher Today?August 30, 2023 | finance.yahoo.comNanoVibronix Announces $5 Million Private Placement Priced At-The-Market Under Nasdaq RulesAugust 30, 2023 | investorplace.comWhy Is NanoVibronix (NAOV) Up 153% Today?August 30, 2023 | finance.yahoo.comNanoVibronix Cites Positive Results from Independent Testing of UroShieldAugust 29, 2023 | finance.yahoo.comNanoVibronix Responds to CMS’ Determination for PainShieldSee More Headlines Receive NAOV Stock News and Ratings via Email Sign-up to receive the latest news and ratings for NanoVibronix and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings4/08/2024Today5/15/2024Next Earnings (Estimated)5/20/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical appliances & supplies Sub-IndustryN/A Current SymbolNASDAQ:NAOV CUSIPN/A CIK1326706 Webwww.nanovibronix.com Phone(914) 233-3004Fax914-376-6111Employees10Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($2.13) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-3,710,000.00 Net Margins-162.55% Pretax Margin-161.28% Return on Equity-123.23% Return on Assets-65.46% Debt Debt-to-Equity RatioN/A Current Ratio2.64 Quick Ratio1.53 Sales & Book Value Annual Sales$2.28 million Price / Sales0.87 Cash FlowN/A Price / Cash FlowN/A Book Value$1.95 per share Price / Book0.37Miscellaneous Outstanding Shares2,780,000Free Float2,684,000Market Cap$1.98 million OptionableNot Optionable Beta1.30 The Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.Get This Free Report Key ExecutivesMr. Brian M. Murphy (Age 67)CEO & Director Comp: $342.5kMr. Stephen R. Brown CPA (Age 68)Chief Financial Officer Comp: $276.5kDr. Harold Jacob M.D. (Age 70)Chief Medical Officer & Director Mr. Amir RippelVice President of MarketingMs. Lindsey HarrisonVice President of SalesKey CompetitorsBone BiologicsNASDAQ:BBLGHeart Test LaboratoriesNASDAQ:HSCSPredictive OncologyNASDAQ:POAIGalmed PharmaceuticalsNASDAQ:GLMDAclarionNASDAQ:ACONView All Competitors NAOV Stock Analysis - Frequently Asked Questions How have NAOV shares performed in 2024? NanoVibronix's stock was trading at $1.15 at the start of the year. Since then, NAOV shares have decreased by 34.8% and is now trading at $0.75. View the best growth stocks for 2024 here. When is NanoVibronix's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Monday, May 20th 2024. View our NAOV earnings forecast. How were NanoVibronix's earnings last quarter? NanoVibronix, Inc. (NASDAQ:NAOV) posted its quarterly earnings results on Monday, April, 8th. The company reported ($0.39) earnings per share for the quarter. The business earned $1.18 million during the quarter. NanoVibronix had a negative trailing twelve-month return on equity of 123.23% and a negative net margin of 162.55%. When did NanoVibronix's stock split? NanoVibronix shares split on Thursday, October 13th 2022. The 2-1 split was announced on Thursday, October 13th 2022. The newly created shares were issued to shareholders after the closing bell on Thursday, October 13th 2022. An investor that had 100 shares of stock prior to the split would have 200 shares after the split. What other stocks do shareholders of NanoVibronix own? Based on aggregate information from My MarketBeat watchlists, some companies that other NanoVibronix investors own include T2 Biosystems (TTOO), ADMA Biologics (ADMA), Co-Diagnostics (CODX), Inovio Pharmaceuticals (INO), Tonix Pharmaceuticals (TNXP), BIO-key International (BKYI), Digital Ally (DGLY), iBio (IBIO) and How do I buy shares of NanoVibronix? Shares of NAOV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:NAOV) was last updated on 5/16/2024 by MarketBeat.com Staff From Our PartnersHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportBiden to Drop BOMBSHELL June 13th?Paradigm PressRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldElon to Transform U.S. Economy? Porter & CompanyCharles Payne Demystifies OptionsUnstoppable ProsperityThe most important AI company you've never heard ofManward PressThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyWATCH: The Truth About InflationBirch Gold Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NanoVibronix, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.